“…Tanshinone IIA (Tan IIA), an effective active ingredient of Salvia miltiorrhiza, is often used clinically for the treatment of ischemic heart disease because of its pharmacological actions such as improving coronary circulation (Jiang et al, ), lowering blood lipids (Kang et al, ), inhibiting platelet aggregation and thrombus formation (Li, Yang, & Zhao, ), retarding development of arteriosclerosis (Adams, Wang, Yang, & Lien, ), decreasing inflammatory reaction (Fan et al, ), and etc. In addition, many studies have shown that Tan IIA has antitumor effects and can kill a variety of cancer cells, including breast cancer cells (Lin et al, ), gastric cancer cells (Chen, Shi, Liu, & Zhong, ), colon cancer cells (Liu et al, ), prostate cancer cells (Won et al, ), and etc. Because one of the main toxic side effects of Dox is cardiotoxicity, and TanIIA not only has antitumor activity but also cardiovascular protective effect, therefore, we combined Dox with Tan IIA to assess the effect of Tan IIA on the toxic side effects of Dox while evaluating its effect on the anti‐breast cancer activity of Dox and to investigate the possible mechanism of the effect of Tan IIA on the anti‐breast cancer activity of Dox.…”